Abstract
Summary
Bone density has been followed up for 20 months following completion of a trial which compared calcium 1,200 mg/day with placebo, in normal older men. Following cessation of calcium supplements, there is a small residual benefit in total body bone density, but not at the hip or spine.
Introduction
Calcium supplements, or supplements of calcium-rich foods, have a positive effect on bone mineral density (BMD). However, it is uncertain whether there are any residual benefits of calcium on BMD following cessation of supplementation.
Methods
In a previously published study, 323 healthy men were randomized to receive elemental calcium 600 mg/day (n = 108), calcium 1,200 mg/day (n = 108), or placebo (n = 107) over 2 years. Consenting men from the placebo and calcium 1,200 mg/day groups (85 and 87, respectively) were followed over the next 1–2 years (mean 20 months), off trial medication.
Results
In the core trial, BMD increased at all sites by 1.0–1.5 % at 2 years in the group receiving calcium 1,200 mg/day, compared to the group receiving placebo. In post-trial follow-up, the calcium group has some residual benefit at the total body (0.41 % above placebo; P = 0.04) but there was no significant between-group differences at other sites.
Conclusion
Following cessation of calcium supplements in healthy men, there is a small residual benefit in total body BMD, but not at the hip or spine. This is unlikely to confer a clinically significant dividend in terms of ongoing fracture prevention.
Similar content being viewed by others
References
Bolland MJ, Barber PA, Doughty RN et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262–266
Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:C3691
Bauer DC (2013) Calcium supplements and fracture prevention. N Engl J Med 369:1537–1543
Manson JE, Bassuk SS (2014) Calcium supplements: do they help or harm? Menopause 21:106–108
Bolland MJ, Grey A, Reid IR (2014) Translation of research into clinical practice: a case study of calcium supplement prescribing in New Zealand. NZ Med J 127:http://journal.nzma.org.nz/journal/127-1401/6277/
Daly RM, Brown M, Bass S et al (2006) Calcium- and vitamin D-3-fortified milk reduces bone loss at clinically relevant skeletal sites in older men: a 2-year randomized controlled trial. J Bone Miner Res 21:397–405
Reid IR, Mason B, Horne A et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119:777–785
Lee WTK, Leung SSF, Leung DMY et al (1996) A follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of children. Am J Clin Nutr 64:71–77
Daly RM, Petrass N, Bass S et al (2008) The skeletal benefits of calcium- and vitamin D-3-fortified milk are sustained in older men after withdrawal of supplementation: an 18-mo follow-up study. Am J Clin Nutr 87:771–777
Dawson-Hughes B, Harris SS, Krall EA et al (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. Am J Clin Nutr 72:745–750
Radford LT, Bolland MJ, Mason B et al (2014) The Auckland calcium study: 5-year post-trial follow-up. Osteoporos Int 25:297–304
Reid IR, Ames R, Mason B et al (2008) Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Int Med 168:2276–2282
Umaretiya PJ, Thacher TD, Fischer PR et al (2013) Bone mineral density in Nigerian children after discontinuation of calcium supplementation. Bone 55:64–68
Bischoff-Ferrari HA, Rees JR, Grau MV et al (2008) Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial. Am J Clin Nutr 87:1945–1951
Cauley JA, Chlebowski RT, Wactawski-Wende J et al (2013) Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the women’s health initiative. J Women’s Health 22:915–929
Porthouse J, Cockayne S, King C et al (2005) Randomised controlled trial of supplementation with calcium and cholecalciferol (vitamin D) for prevention of fractures in primary care. BMJ 330:1003–1006
RECORD Trial Group (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomized evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621–1628
Prince RL, Devine A, Dhaliwal SS et al (2006) Effects of calcium supplementation on clinical fracture and bone structure—results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Int Med 166:869–875
Salovaara K, Tuppurainen M, Karkkainen M et al (2010) Effect of vitamin D-3 and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial—the OSTPRE-FPS. J Bone Miner Res 25:1487–1495
Reid IR, Bolland MJ (2014) Calcium risk-benefit updated-new WHI analyses. Maturitas 77:1–3
Moyer VA, U. S. Preventive Services Task Force (2013) Vitamin D and calcium supplementation to prevent fractures in adults: US preventive services task force recommendation statement. Ann Intern Med 158:691–696
Chailurkit LO, Saetung S, Thakkinstian A et al (2010) Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clin Endocrinol 73:167–172
Acknowledgment
The study was supported by the Health Research Council of New Zealand (Grant No. 12/1110).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ruth Ames passed away following completion of this study.
Rights and permissions
About this article
Cite this article
Kalluru, R., Ames, R., Mason, B. et al. Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial. Osteoporos Int 26, 173–178 (2015). https://doi.org/10.1007/s00198-014-2896-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2896-x